Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes

Figure 2

Event-free survival for bleeding events defined by the BARC criteria in ACS patients with diabetes. The incidence of bleeding events in the ticagrelor group (red line) was higher than that in the clopidogrel group (blue line) (HR 1.76, 95% CI 1.00–3.10, ).